HUM monthly performance report
Monthly HUM research: returns, drawdown, relative strength, seasonality, and key stats.
HUM monthly report
—
Key takeaways
- Humana (HUM) closed August 2026 at $363.82, down 0.01% for the month and +42.97% over the trailing 12 months.
- Year-to-date, HUM is +42.05%, outperforming the S&P 500 which has returned +12.89% YTD.
- The stock is trading +37.42% versus its 200-day moving average ($264.75), a bullish technical signal.
- Over the past three years, HUM has underperformed the S&P 500 by −97.16%, with a relative strength index reading of 43.1.
- Win rate over the trailing 39 months stands at 43.6% — 17 positive months versus 22 negative months.
Humana ended August 2026 at $363.82, posting a monthly return of −0.01%. The S&P 500 returned +3.05% over the same window, leaving relative performance at −3.06%.
The current quarter stands at −10.69% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +37.42% versus the 200-day moving average ($264.75).
Year-to-date, HUM is +42.05% against SPY +12.89%, a gap of +29.16%. The stock is currently −15.17% below its 52-week high, with maximum 3-year drawdown at −68.78%.
| Period | HUM | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +0.46% | −0.20% | +0.66% |
| 1 Week | −6.40% | +3.90% | −10.31% |
| 1 Month | −0.01% | +3.05% | −3.06% |
| 3 Months | +53.87% | +7.11% | +46.76% |
| 6 Months |